Alphabet is expected to benefit from the AI trend in 2026, with Google Cloud gaining traction and Gemini 3.0 enhancing search capabilities. Vertex Pharmaceuticals has growth drivers like Alyftrek and Journavx, with Povetacicept showing promise. Enbridge offers stability and growth potential with a high dividend yield and $50 billion in growth opportunities. Consider investing in these stocks for the new year.

Read more at Nasdaq: The Best Stocks to Invest $1,000 in to Start the New Year Off Right